ARCA biopharma presents data from phase 3 Ideal trial of Gencaro ARCA biopharma.

The data will be presented during the Retina: Dry out AMD part of the ISOPT program on Saturday, December 5, 2009 at 10:20 a.m. CET in Hall A of the Rome Cavalieri Hilton. Related StoriesDrug used to treat Parkinson's and related diseases may delay or prevent macular degenerationResearchers discover that vitamin D may play significant role in preventing AMD among womenAllergan indicators licensing agreement with Mimetogen to build up, commercialize tavilermide for treatment of dry out eyesight diseaseNancy Boman, M.D., Ph.D.She has been recognized as one of the most influential ladies in sustainable advancement and in the cleantech sector and a strong track record of expense in the sector. The knowledge of Agrisoma associates and the grade of the technological development have convinced Routine Capital to become listed on this promising project for a greener economy. In addition, Agrisoma announces the appointment of Rick Smith, Recent CEO and President in Dow AgroSciences Canada Inc., to the Board and also John Plaza, CEO and President and Founder of Imperium Renewables, an international leader in next generation biofuel production. I am excited to welcome our fresh Board members, who provide a depth of experience in financing, clean technology, agriculture and renewable fuels. We are looking towards drawing on their encounter as we continue to grow the ongoing organization.